Seeking Alpha

Novartis (NVS) is due to appear before India's Supreme Court on Wednesday in an attempt to gain...

Novartis (NVS) is due to appear before India's Supreme Court on Wednesday in an attempt to gain patent protection for its leading cancer-drug Glivec, which the Indian government declined to provide. The case comes as India, although suffering from a slowing economy and high inflation, becomes increasingly unpredictable and unfriendly for foreign companies.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector